Investing in Life Sciences companies

Solving Important medical needs

Supporting entrepreneurs and scientific teams

MISSION

Panakes is a venture capital firm with the ultimate goal of providing a better life to people all around the world.
We back promising teams by providing both financial and business support to build the next generation of game-changing technologies companies in the field of Life Sciences.

We invest in ambitious early stage start-ups and SMEs with innovative products globally, mainly across Europe and Israel.

We bring strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our founders in accelerating their development.

We invest in people, believing that a strong and dedicated team is one of the most important factors in the success of our investments. We aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor.

We invest for people, supporting the growth of companies and people that will reshape the medical world, answering real medical needs, saving lives and providing a better quality of life for patients and care-givers.

An overall positive impact that will produce intrinsic value for both investors and society.

TEAM

Fabrizio Landi

Fabrizio Landi

Founder and Managing Partner
Alessio Beverina

Alessio Beverina

Founder and Managing Partner
Diana Saraceni

Diana Saraceni

Founder and Managing Partner
Barbara Castellano

Barbara Castellano

Partner
Rob Woodman

Rob Woodman

Partner
Marco Sardina

Marco Sardina

Scientific Partner
Alessio Piuma

Alessio Piuma

Investment Manager
Andrea Ballerini

Andrea Ballerini

Associate
Michele Alloni

Michele Alloni

Analyst
Giacomo Piccinini

Giacomo Piccinini

Associate
Lorenzo Giordano

Lorenzo Giordano

CFO
Paola Crovato

Paola Crovato

Office and Deal Flow Manager
Federica Porcu

Federica Porcu

Financial Controller and ESG Manager
Michela Barcella

Michela Barcella

Network and Portfolio Talent Advisor

ADVISORS

SERGIO ABRIGNANI

SERGIO ABRIGNANI

Scientific Director INGM (Istituto Nazionale di Genetica Molecolare)
ANTONELLO BISCINI

ANTONELLO BISCINI

Former VP Biz
Dev Diagnostic
Menarini Group
PAOLA CASTAGNOLI

PAOLA CASTAGNOLI

Scientific Director Fondazione Toscana Life Sciences
FABRIZIO CHINES

FABRIZIO CHINES

Executive Chairman & CEO SIFI
VALENTINA COGLIATI

VALENTINA COGLIATI

CEO Elemaster
MAURIZIO COLOMBO

MAURIZIO COLOMBO

Owner & Executive VP Sapiolife
EMANUELE GATTI

EMANUELE GATTI

Former CEO EMEA Fresenius Medical Care
MASSIMO MERCATI

MASSIMO MERCATI

CEO Aboca
SIMONE RE

SIMONE RE

CEO Digitec Innovation
LUCIO ROVATI

LUCIO ROVATI

CEO & Chairman Rottapharm
RAFFAELE VENAFRO

RAFFAELE VENAFRO

Founder Crossmed

PORTFOLIO

Dermatology - Atopic Dermatitis
Surgery - Surgical Smoke Removal
Ophtalmology - presbyopia
Cardiovascular - Tricuspid Therapy
Oncology – Nuclear Medicine
Oncology - Blood Brain Barrier opening
Biotech - Age-Related Macular Degeneration
In-Vitro Diagnostic - Alzheimer
Biotech - Oncology
Cardiovascular - Ventricular Tachycardia treatment
In-Vivo Diagnostic - Osteoporosis
Endoscopy – GI tract accessory
Biotech - respiratory diseases
Cardiovascular - Mitral Valve replacement
Robotic - Microsurgery
Neuromodulation - Tinnitus
Biotech - Oncology vaccine
Neuromodulation – Migraine
Oncology - Margin Assessment
Cardiovascular - Closure Device

NEWS

image news
Certaldo, Italy, March 26, 2024

Endostart receives FDA 510(k) clearance for Endorail®, ushering in new era of gastrointestinal endoscopy innovation

image news
JACKSONVILLE, Fla, 8 April 2024

MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S.

image news
JACKSONVILLE, Fla. – February 21, 2024

MMI Raises $110 Million in Series C Financing

Vedi altre